[1]
Feryal Hashim Rada, “Adequacy of Olmesartan monotherapy versus cotherapy in patients with essential hypertension”, Int. J. Res. Pharm. Sci., vol. 11, no. 2, pp. 1649–1654, Apr. 2020.